NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains

被引:9
作者
Benzine, Tiffany [1 ,2 ]
Brandt, Ryan [3 ]
Lovell, William C. [1 ]
Yamane, Daisuke [1 ]
Neddermann, Petra [4 ]
De Francesco, Raffaele [4 ]
Lemon, Stanley M. [1 ,2 ]
Perelson, Alan S. [5 ]
Ke, Ruian [3 ]
McGivern, David R. [1 ,2 ]
机构
[1] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ North Carolina Chapel Hill, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA
[3] North Carolina State Univ, Dept Math, Raleigh, NC USA
[4] INGM Ist Nazl Genet Mol Romeo & Enrica Invernizzi, Milan, Italy
[5] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM USA
基金
美国国家卫生研究院;
关键词
MEMBRANOUS REPLICATION; LIPID-PEROXIDATION; RNA REPLICATION; HCV REPLICATION; GENE-EXPRESSION; CELL-CULTURE; PROTEIN; REDISTRIBUTION; MICROTUBULES; DACLATASVIR;
D O I
10.1371/journal.ppat.1006343
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C virus (HCV) RNA is synthesized by the replicase complex (RC), a macromolecular assembly composed of viral non-structural proteins and cellular co-factors. Inhibitors of the HCV NS5A protein block formation of new RCs but do not affect RNA synthesis by preformed RCs. Without new RC formation, existing RCs turn over and are eventually lost from the cell. We aimed to use NS5A inhibitors to estimate the half-life of the functional RC of HCV. We compared different cell culture-infectious strains of HCV that may be grouped based on their sensitivity to lipid peroxidation: robustly replicating, lipid peroxidation resistant (LPOR) viruses (e.g. JFH-1 or H77D) and more slowly replicating, lipid peroxidation sensitive (LPOS) viruses (e.g. H77S. 3 and N.2). In luciferase assays, LPOS HCV strains declined under NS5A inhibitor therapy with much slower kinetics compared to LPOR HCV strains. This difference in rate of decline was not observed for inhibitors of the NS5B RNA-dependent RNA polymerase suggesting that the difference was not simply a consequence of differences in RNA stability. In further analyses, we compared two isoclonal HCV variants: the LPOS H77S. 3 and the LPOR H77D that differ only by 12 amino acids. Differences in rate of decline between H77S. 3 and H77D following NS5A inhibitor addition were not due to amino acid sequences in NS5A but rather due to a combination of amino acid differences in the non-structural proteins that make up the HCV RC. Mathematical modeling of intracellular HCV RNA dynamics suggested that differences in RC stability (half-lives of 3.5 and 9.9 hours, for H77D and H77S. 3, respectively) are responsible for the different kinetics of antiviral suppression between LPOS and LPOR viruses. In nascent RNA capture assays, the rate of RNA synthesis decline following NS5A inhibitor addition was significantly faster for H77D compared to H77S. 3 indicating different half-lives of functional RCs.
引用
收藏
页数:20
相关论文
共 37 条
  • [1] Daclatasvir-Like Inhibitors of NS5A Block Early Biogenesis of Hepatitis C Virus-Induced Membranous Replication Factories, Independent of RNA Replication
    Berger, Carola
    Romero-Brey, Ines
    Radujkovic, Danijela
    Terreux, Raphael
    Zayas, Margarita
    Paul, David
    Harak, Christian
    Hoppe, Simone
    Gao, Min
    Penin, Francois
    Lohmann, Volker
    Bartenschlager, Ralf
    [J]. GASTROENTEROLOGY, 2014, 147 (05) : 1094 - +
  • [2] Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity
    Bianco, Annalisa
    Reghellin, Veronica
    Donnici, Lorena
    Fenu, Simone
    Alvarez, Reinaldo
    Baruffa, Chiara
    Peri, Francesco
    Pagani, Massimiliano
    Abrignani, Sergio
    Neddermann, Petra
    De Francesco, Raffaele
    [J]. PLOS PATHOGENS, 2012, 8 (03):
  • [3] Replication Vesicles are Load- and Choke-Points in the Hepatitis C Virus Lifecycle
    Binder, Marco
    Sulaimanov, Nurgazy
    Clausznitzer, Diana
    Schulze, Manuel
    Hueber, Christian M.
    Lenz, Simon M.
    Schloeder, Johannes P.
    Trippler, Martin
    Bartenschlager, Ralf
    Lohmann, Volker
    Kaderali, Lars
    [J]. PLOS PATHOGENS, 2013, 9 (08)
  • [4] Protein Friction Limits Diffusive and Directed Movements of Kinesin Motors on Microtubules
    Bormuth, Volker
    Varga, Vladimir
    Howard, Jonathon
    Schaeffer, Erik
    [J]. SCIENCE, 2009, 325 (5942) : 870 - 873
  • [5] Dumont ELP, 2015, NAT NANOTECHNOL, V10, P166, DOI [10.1038/nnano.2014.334, 10.1038/NNANO.2014.334]
  • [6] Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
    Gao, Min
    Nettles, Richard E.
    Belema, Makonen
    Snyder, Lawrence B.
    Nguyen, Van N.
    Fridell, Robert A.
    Serrano-Wu, Michael H.
    Langley, David R.
    Sun, Jin-Hua
    O'Boyle, Donald R.
    Lemm, Julie A.
    Wang, Chunfu
    Knipe, Jay O.
    Chien, Caly
    Colonno, Richard J.
    Grasela, Dennis M.
    Meanwell, Nicholas A.
    Hamann, Lawrence G.
    [J]. NATURE, 2010, 465 (7294) : 96 - U108
  • [7] Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics
    Guedj, J.
    Neumann, A. U.
    [J]. JOURNAL OF THEORETICAL BIOLOGY, 2010, 267 (03) : 330 - 340
  • [8] Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938
    Guedj, Jeremie
    Pang, Phillip S.
    Denning, Jill
    Rodriguez-Torres, Maribel
    Lawitz, Eric
    Symonds, William
    Perelson, Alan S.
    [J]. ANTIVIRAL THERAPY, 2014, 19 (02) : 211 - 220
  • [9] Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
    Guedj, Jeremie
    Dahari, Harel
    Rong, Libin
    Sansone, Natasha D.
    Nettles, Richard E.
    Cotler, Scott J.
    Layden, Thomas J.
    Uprichard, Susan L.
    Perelson, Alan S.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (10) : 3991 - 3996
  • [10] The Cyclophilin Inhibitor SCY-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A Complexes
    Hopkins, Sam
    Bobardt, Michael
    Chatterji, Udayan
    Garcia-Rivera, Jose A.
    Lim, Precious
    Gallay, Philippe A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3888 - 3897